financetom
Business
financetom
/
Business
/
TD SYNNEX Q2 Gross Billings Soar Double Digits
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
TD SYNNEX Q2 Gross Billings Soar Double Digits
Jun 24, 2025 7:26 AM

TD SYNNEX Corp ( SNX ). shares traded higher on Tuesday after the company reported its second-quarter 2025 results.

Quarterly revenue rose 7.2% year over year (yoy) to $14.95 billion, topping the high end of the company's guidance and beating analysts' estimate of $14.32 billion.

On a constant currency basis, revenue rose 6.3%, led by growth in Endpoint and Advanced Solutions. A shift in product mix reduced reported revenue by about 5% year over year.

Also Read: Top Wall Street Forecasters Revamp TD Synnex Expectations Ahead Of Q2 Earnings

Americas revenue grew 5.3% to $9.0 billion; gross billings rose 9% to $13.3 billion. Operating income hit $253 million with a 2.8% margin.

Europe revenue rose 10.5% to $4.9 billion, with gross billings up 16.7% to $6.8 billion. Operating income reached $50 million with a 1.0% margin.

Asia-Pacific and Japan revenue grew 8.7% to $1.0 billion, with gross billings up 22% to $1.5 billion. Operating income was $25 million with a 2.4% margin.

Non-GAAP gross billings rose 12.1% yoy to $21.6 billion, exceeding the high end of the company's outlook. On a constant currency basis, gross billings increased 11.3%.

Gross profit reached $1.05 billion, up from $974 million, with gross margin steady at 7.0%, helped by a 31-basis-point lift from product mix.

Operating income was $328 million, compared to $264 million, while non-GAAP operating income totaled $414 million versus $388 million. The operating margin improved to 2.2% from 1.9%, while the non-GAAP operating margin remained at 2.8%.

The Fremont, California-based company reported an adjusted EPS of $2.99, topping the street view of $2.72.

Operating cash flow totaled $573 million, up from a $115 million outflow last year. Free cash flow reached $543 million, compared to a negative $153 million. Shareholder returns were $186 million, down from $288 million.

TD SYNNEX's ( SNX ) Board of Directors declared a quarterly cash dividend of 44 cents per share, payable on July 25, 2025, to stockholders of record as of the close of business on July 11, 2025.

Outlook

TD SYNNEX ( SNX ) expects third-quarter adjusted EPS of $2.75-$3.25, compared to the estimate of $2.96.

The company projects revenue of $14.7 billion to $15.5 billion versus the estimated $15.02 billion. Additionally, gross billings are projected to be between $21 billion and $22 billion.

Price Action: SNX shares were trading higher by 4.35% to $133.15 at last check Tuesday.

Read Next:

PepsiCo Taps Salesforce To Deploy Agentforce For AI-Driven Growth

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Vera Therapeutics Says Trial of Kidney Disease Drug Achieves Primary Endpoint; Shares Jump
Vera Therapeutics Says Trial of Kidney Disease Drug Achieves Primary Endpoint; Shares Jump
Jun 2, 2025
10:31 AM EDT, 06/02/2025 (MT Newswires) -- Vera Therapeutics ( VERA ) shares climbed by nearly 60% in recent Monday trading after the biotechnology firm said a phase 3 trial of atacicept to treat immunoglobulin A nephropathy in adults achieved its primary endpoint. The primary efficacy endpoint was the change in 24-hour urine protein-to-creatinine ratio versus placebo at the 36-week...
ConnectOne Bancorp Completes Merger With First of Long Island
ConnectOne Bancorp Completes Merger With First of Long Island
Jun 2, 2025
10:32 AM EDT, 06/02/2025 (MT Newswires) -- ConnectOne Bancorp ( CNOB ) said Monday it completed its merger with First of Long Island ( FLIC ) . The combined company is operating under the ConnectOne brand and has about $14 billion in assets. First of Long Island ( FLIC ) shareholders received 0.5175 shares of ConnectOne common stock for each...
Ascendis' New Drug Application for Investigational Drug to Treat Genetic Disorder Accepted by FDA for Priority Review
Ascendis' New Drug Application for Investigational Drug to Treat Genetic Disorder Accepted by FDA for Priority Review
Jun 2, 2025
10:34 AM EDT, 06/02/2025 (MT Newswires) -- Ascendis Pharma ( ASND ) said Monday its new drug application for the TransCon CNP candidate to treat children with achondroplasia, a genetic condition, was accepted by the US Food and Drug Administration for priority review. The FDA set a prescription drug user fee act date of November 30 to close the review...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved